Evolent Health Inc. logo

Evolent Health Inc.

EVH | NYSE
Chart Builder DCF Calculator
$3.69
$0 (0.00%)
At close: Sep 21, 2026, 4:00 PM ET
$3.69
$0 (0.00%)
After-hours: Sep 21, 2026, 4:01 PM ET

Market Data

Market Cap
$415.06M
Enterprise Value
$303.32M
Beta
0.84
Average Volume
2.96M
Shares Outstanding (Diluted)
112.54M
Shares Change YoY
-2.88%
Institutional Ownership
99.00%
Exchange
NYSE
ISIN
US30050B1017

Price Performance

Price Change 1M
-21.0%
Price Change 3M
-23.1%
Price Change 6M
62.6%
Price Change YTD
-5.1%
Price Change 1Y
-57.0%
Price Change 3Y
-86.1%
Price Change 5Y
-85.9%
1M CAGR (ann.)
2.8%
1Y CAGR (ann.)
-56.8%
5Y CAGR (ann.)
-31.9%
All-Time CAGR
-13.4%

Valuation

PE Ratio
-0.82
Forward PE
9.38
PEG Ratio
0.00
Forward PEG
-0.01
PS Ratio
0.20
Forward PS
0.10
PB Ratio
1.08
P/FCF Ratio
24.49
P/Adj. FCF Ratio
-19.59
P/OCF Ratio
7.85
EV/Sales
0.14
EV/EBIT
-0.70
EV/EBITDA
-0.96
EV/FCF
17.90
Earnings Yield
-121.7%
FCF Yield
4.1%
Adj. FCF Yield
-5.1%

Financial Health

Net Cash
$111.74M
Total Debt
$3.97M
Cash & Short-Term Investments
$115.7M
Total Assets
$1.97B
Current Ratio
1.24
Quick Ratio
1.24
Debt / Equity Ratio
2.53
Debt / EBITDA
-0.01
Debt / FCF
0.23
OCF / Debt
13.44
Interest Coverage
-0.41
Altman Z-Score
-0.41
Piotroski F-Score
6

Margins & Profitability

Gross Profit Margin
12.9%
Operating Profit Margin
-1.4%
EBITDA Margin
-15.1%
Net Profit Margin
-24.1%
FCF Margin
0.8%
Adj. FCF Margin
-1.0%
SBC / Revenue
1.8%
SBC Impact (per share)
-225.0%

Returns

Return on Assets
-25.6%
Return on Equity
-99.2%
Return on Invested Capital
-1.9%
Return on Capital Employed
-1.9%
Return on Tangible Assets
-69.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
8.7%
Revenue CAGR 5Y
17.2%
Revenue CAGR 10Y
27.0%
EPS CAGR 3Y
-75.6%
EPS CAGR 5Y
-58.9%
EPS CAGR 10Y
-5.9%
FCF CAGR 3Y
-191.9%
FCF CAGR 5Y
-34.8%
FCF CAGR 10Y
57.0%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
30
EPS Growth Next 3Y
37.9%
Revenue Growth Next 3Y
25.2%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
$0.06
EPS Growth Est (next Q)
20.0%
Revenue Est (next Q)
$728.57M
Revenue Growth Est (next Q)
51.9%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$7
Price Target Upside
89.7%

Cash Flow

Operating Cash Flow
$53.33M
Free Cash Flow
$16.95M
Adj. Free Cash Flow
$-21.19M
FCF Per Share
$0.15
OCF Per Share
$0.47
OCF/S Ratio
2.5%

Income Statement

Revenue
$2.1B
Gross Profit
$270.83M
Operating Income
$-28.68M
EBITDA
$-317.04M
Net Income
$-504.99M
EPS (Diluted)
-$4.49
Revenue / Employee
$499.29K
Profit / Employee
$-120.24K
Employees
4,200

© 2026 bestshares.com. All rights reserved.